Galux
Develops AI-driven protein design platform for de novo antibody and drug discovery
$29MSeries B
Role not disclosedSI
SneakPeek Investments
Activity from announced rounds
Activity in this selectionhico-ventures-db742f76
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $29M 1 disclosed · full round size, not this investor’s share